Canon Stroke and Vascular Research Center, University at Buffalo - Clinical and Translational Research Center, State University of New York, Buffalo, NY, USA.
Department of Neurosurgery, University at Buffalo, State University of New York, Buffalo, NY, USA.
Neurosurg Rev. 2021 Oct;44(5):2545-2570. doi: 10.1007/s10143-021-01481-w. Epub 2021 Jan 26.
The pathogenesis and natural history of intracranial aneurysm (IA) remains poorly understood. To this end, animal models with induced cerebral vessel lesions mimicking human aneurysms have provided the ability to greatly expand our understanding. In this review, we comprehensively searched the published literature to identify studies that endogenously induced IA formation in animals. Studies that constructed aneurysms (i.e., by surgically creating a sac) were excluded. From the eligible studies, we reported information including the animal species, method for aneurysm induction, aneurysm definitions, evaluation methods, aneurysm characteristics, formation rate, rupture rate, and time course. Between 1960 and 2019, 174 articles reported endogenous animal models of IA. The majority used flow modification, hypertension, and vessel wall weakening (i.e., elastase treatment) to induce IAs, primarily in rats and mice. Most studies utilized subjective or qualitative descriptions to define experimental aneurysms and histology to study them. In general, experimental IAs resembled the pathobiology of the human disease in terms of internal elastic lamina loss, medial layer degradation, and inflammatory cell infiltration. After the early 2000s, many endogenous animal models of IA began to incorporate state-of-the-art technology, such as gene expression profiling and 9.4-T magnetic resonance imaging (MRI) in vivo imaging, to quantitatively analyze the biological mechanisms of IA. Future studies aimed at longitudinally assessing IA pathobiology in models that incorporate aneurysm growth will likely have the largest impact on our understanding of the disease. We believe this will be aided by high-resolution, small animal, survival imaging, in situ live-cell imaging, and next-generation omics technology.
颅内动脉瘤 (IA) 的发病机制和自然史仍知之甚少。为此,模拟人类动脉瘤的脑血管病变的动物模型提供了极大地扩展我们认识的能力。在这篇综述中,我们全面搜索了已发表的文献,以确定在动物中内源性诱导 IA 形成的研究。排除了构建动脉瘤的研究(即通过手术形成囊)。从合格的研究中,我们报告了包括动物物种、动脉瘤诱导方法、动脉瘤定义、评估方法、动脉瘤特征、形成率、破裂率和时间进程在内的信息。1960 年至 2019 年期间,有 174 篇文章报道了内源性 IA 动物模型。大多数使用血流改型、高血压和血管壁弱化(即弹性蛋白酶处理)来诱导 IA,主要在大鼠和小鼠中进行。大多数研究使用主观或定性描述来定义实验性动脉瘤并进行组织学研究。总的来说,实验性 IA 在内部弹性层丧失、中层降解和炎症细胞浸润方面与人类疾病的病理生物学相似。在 21 世纪初,许多内源性 IA 动物模型开始采用基因表达谱分析和 9.4-T 磁共振成像(MRI)体内成像等最先进的技术,对 IA 的生物学机制进行定量分析。未来旨在在纳入动脉瘤生长的模型中对 IA 病理生物学进行纵向评估的研究可能会对我们对该疾病的理解产生最大影响。我们相信,这将得益于高分辨率、小动物、存活成像、原位活细胞成像和下一代组学技术的发展。